Try our Advanced Search for more refined results
IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Lieff Cabraser
- Sarraf Gentile
- Baker Botts
- K&L Gates
- Foley & Lardner
- Kirkland & Ellis
- Andrus Anderson
- McCune Law
- Patterson Belknap
- Fiddler Gonzalez
- Ahern and Associates
- Spiro Harrison
- Harkins Cunningham
- Axinn Veltrop
- Cicala Law Firm
- Burns Charest
- Gustafson Gluek
- Armstrong Teasdale
- Levin Sedran
- Kohn Swift
- Cleary Gottlieb
- Tostrud Law Group
- Wilson Sonsini
- Skadden Arps
- Gross & Belsky
- Tycko & Zavareei
- Freedman Boyd
- Girard Sharp
- Steyer Lowenthal
- Zelle LLP
- Cera LLP
- Garwin Gerstein
- Krantz & Berman
- Lockridge Grindal
- Rosenn Jenkins
- Barrack Rodos
- Obermayer Rebmann
- Schneider Wallace
- Cole Schotz
- Anselmi & Carvelli
- Saiber LLC
- Cuneo Gilbert
- Stradley Ronon
- Welsh & Recker
- DeCotiis FitzPatrick
- Berry Law LLC
- Motley Rice
- Pendley Baudin
- Zwerling Schachter
- Rule Garza
- Earp Cohn
- Hogan Lovells
- Joseph Saveri Law Firm
- Competition Law Partners
- Seeger Weiss
- King & Spalding
- WilmerHale
- Larson King
- Barrett Law Group
- McConnell Valdes
- Safirstein Law
- Stueve Siegel
- Polsinelli PC
- Neufeld Scheck
- Spector Roseman
- Robbins Geller
- Neal & Harwell
- Norton Rose
- Goldman Scarlato
- Heins Mills
- Hunt Ortmann
- Hach Rose Schirripa
- Edelson Lechtzin
- Ricci Tyrrell
- Schertler Onorato
- Fenwick & West
- Wiggin & Dana
- Faruqi & Faruqi
- Shinder Cantor
- Wexler Boley
- Roberts Law Firm US
- Kasowitz Benson
- Walsh Pizzi
- Boni Zack
- Stevens & Lee
- Zuckerman Spaeder
- Williams & Connolly
- Lyden Chappell
- Barnes & Thornburg
- Segal McCambridge
- Grabar Law
- Calcaterra Pollack
- Hagens Berman
- Bonsignore Trial Lawyers
- Buchanan Ingersoll
- Reed Smith
- Napoli Shkolnik
- DiCello Levitt
- Carella Byrne
- NastLaw
- McCracken Stemerman
- Wisner Baum
- Manatt Phelps
- George Feldman
- Faegre Drinker
- Bailey Duquette
- Sills Cummis
- Ballard Spahr
- Cozen O'Connor
- Morrison & Foerster
- Debevoise & Plimpton
- Blank Rome
- Goodwin Procter
- DLA Piper
- Francis Mailman
- O'Melveny & Myers
- Nussbaum Law Group
- Bailey & Glasser
- Venable LLP
- Kaplan Fox
- Steptoe LLP
- Marks O'Neill
- Dugan Law Firm
- Shapiro Arato
- Scott&Scott
- Langer Grogan
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Hausfeld LLP
- Kralowec Law
- Furth Salem
- Greenberg Traurig
- Hangley Aronchick
- Gibson Dunn
- Pullman & Comley
- Dilworth Paxson
- Yarborough Law Firm
- Bartlit Beck
- Kelley Drye
- White and Williams
- Morgan Lewis
- Wolf Haldenstein
- Tarter Krinsky
- Cotchett Pitre
- Paul Weiss
- Lowey Dannenberg
- Steven Williams Law
- Taus Cebulash
- Bingham McCutchen
- Dechert LLP
- Seward & Kissel
- Hughes Hubbard
- Winston & Strawn
- Baker & Hostetler
- Simpson Thacher & Bartlett LLP
- Miller & Chevalier
- Lite DePalma
- Berman Tabacco
- Boies Schiller
- Crowell & Moring
- Radice Law Firm
- Whatley Kallas
- Weil Gotshal
- Cohen Milstein
- Proskauer Rose
- Freshfields
- O’Neill & Borges
- Sperling Kenny
- Clark Hill
- Haynes Boone
- Miller Shah
- McDermott Will & Emery
- Duane Morris
- Zimmerman Reed
- Troutman
- Lowenstein Sandler
- Lewis Brisbois
- Berger Montague
- Fox Rothschild
- Glancy Prongay
- Constantine Cannon
- Harris St. Laurent
- Shipman & Goodwin
- Linklaters LLP
- Arnold & Porter
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Saveri & Saveri
- Curtis Mallet-Prevost
- Latham & Watkins
- White & Case
Companies
- Sun Pharmaceutical Industries Ltd.
- Perrigo Co. PLC
- Impax Laboratories, Inc.
- Sandoz International GmbH
- MSP Recovery
- Walgreens Boots Alliance Inc.
- Endo International PLC
- Bausch Health Cos. Inc.
- Cencora Inc.
- Aurobindo Pharma Ltd.
- Dr. Reddy's Laboratories Ltd.
- The Harvard Drug Group LLC
- Lupin Ltd.
- Amneal Pharmaceuticals Inc.
- Lannett Company, Inc
- Health Care Service Corp.
- Glenmark Pharmaceuticals Ltd.
- Taro Pharmaceutical Industries Ltd.
- Bi-Lo
- Humana Inc.
- The Cigna Group
- Viatris Inc.
- Hi-Tech Pharmacal Co., Inc.
- Red Oak Sourcing LLC
- Molina Healthcare Inc.
- Allergan PLC
- Par Pharmaceutical Cos. Inc.
- Fougera Pharmaceuticals Inc.
- United Food & Commercial Workers International Union
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Emcure Pharmaceuticals Ltd.
- Akorn Inc.
- Cardinal Health Inc.
- Avet Pharmaceuticals Inc.
- Camber Pharmaceuticals Inc.
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- G&W Laboratories Inc.
- Upsher-Smith Laboratories Inc.
- McKesson Corp.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- Novartis AG
- American Federation of State County & Municipal Employees
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
January 03, 2019
AGs Blast Generic Cos.' Bid To Gag Price-Fixing Comments
Defending their right to comment publicly on multidistrict litigation and ongoing probes into alleged price-fixing by generic-drug companies, dozens of state attorneys general have told a Pennsylvania federal judge that a speech limitation sought by the drug companies would be unnecessary and unconstitutional.
-
January 01, 2019
Life Sciences Cases To Watch In 2019
The life sciences industry will be keeping an eye on courtrooms around the country in 2019, watching to see how the U.S. Supreme Court decides a legal battle over patent protection for drugs and monitoring the fallout from federal prosecutors' decision to spike a False Claims Act case. Here are seven cases life sciences attorneys say they'll be following in the coming year.
-
December 19, 2018
Generic-Drug Cos. Want AGs To Shut Up About Price-Fixing
Generic-drug companies facing multidistrict litigation and ongoing probes into alleged price-fixing are tired of hearing about them in the news, according to a brief filed in Pennsylvania federal court Tuesday that argues state attorneys general offices have violated legal and ethical requirements to keep mum.
-
November 15, 2018
Judge Won't Quash AGs' Subpoenas In Generic Pricing MDL
The New York and Connecticut attorneys general can keep sending subpoenas to drugmakers as part of their broader investigations into generic-drug price-fixing, a Pennsylvania federal judge has ruled, despite the drug companies’ concern the investigations were circumventing the discovery process for a sprawling multidistrict litigation.
-
November 05, 2018
Humana Seeks Case's Inclusion In Generic Price-Fixing MDL
Humana on Friday asked the Pennsylvania federal court overseeing the sprawling multidistrict litigation over generic drug prices to formally incorporate its action into the MDL, saying its claims target many of the same drugs that the group of states and proposed classes of drug buyers are targeting.
-
October 17, 2018
20 Drugmakers Must Face Generic Price-Fixing MDL
A Pennsylvania federal court has greenlighted the first round of multidistrict litigation accusing more than 20 generic-drug makers of conspiring to fix their prices, excusing only Teligent Inc. from the antitrust litigation.
-
September 26, 2018
McKesson Is Roped Into Generic-Drug Price-Fixing Row
McKesson Corp. earned billions of dollars by cooperating with an industrywide price-fixing conspiracy among generic-drug makers, according to a proposed class action Tuesday that appeared to be one of the first suits linking a drug distributor to multidistrict litigation over alleged drugmaker collusion.
-
January 03, 2018
Generics Buyers Fight To Keep 2 Drugs In Antitrust MDL
Direct purchaser plaintiffs in a large antitrust class action alleging price-fixing of a variety of generic drugs are pushing back against a motion to dismiss claims over two drugs, telling a Pennsylvania federal judge that the complaints contain more than enough of a basis to open discovery.
-
November 15, 2017
State AGs Want Separate Track In Generic Price-Fixing MDL
State attorneys general accusing 18 drug companies of conspiring to fix the prices of 15 generic drugs urged a Pennsylvania federal judge Tuesday to establish a separate government track within the broader multidistrict litigation, saying they can't yield authority to other entities such as private parties' lead counsel and their allegations are too broad to be litigated drug by drug.
-
October 31, 2017
State AGs Triple Size Of Generic Price-Fixing Litigation
The 46 attorneys general accusing six drug companies of conspiring to fix the price of two generic drugs said Tuesday they're asking a Pennsylvania federal court for permission to massively expand their suit by targeting 12 more drug companies, 13 more drugs, and Mylan and Emcure executives.